Karimi-Galougahi Mahboobeh, Safavi Naini Ali, Ghorbani Jahangir, Raad Nasim, Raygani Negar
Chronic Respiratory Disease Research Center, National Research Institute of Tuberculosis and Lung Diseases, Shahid Beheshti University of Medical Sciences, Masih Daneshvari Hospital, Neyavran, Darabad, Tehran, Iran.
Indian J Otolaryngol Head Neck Surg. 2022 Oct;74(Suppl 2):2743-2749. doi: 10.1007/s12070-020-02166-4. Epub 2020 Sep 28.
The present study aimed at evaluating the prevalence of general and sinonasal symptoms in patients with olfactory symptoms and mild coronavirus disease-2019 (COVID-19) and determining the patterns in emergence and resolution of olfactory/gustatory symptoms relative to general and sinonassal symptoms. This was a prospective cross-sectional study conducted at the outpatient otorhinolaryngology clinic at a COVID-19-designated referral Hospital. We included consecutive patients with new-onset olfactory dysfunction and positive polymerase chain reaction (PCR) assay of COVID-19. We asked the patients to fill in a questionnaire about general and sinonasal symptoms in association with anosmia, hyposmia or hypogeusia, and recorded the time course of the olfactory/gustatory symptoms during 2-weeks of follow-up. 76 patients with average age of 38.5 ± 10.6 years were included. Majority of participants (94.7%) had general or sinonasal symptom. There was anosmia in 60.5% and hyposmia in 39.5%, with sudden onset of olfactory symptoms reported in 63.2% of patients. During the follow-up, 30.3% of patients completely and 44.7% partially recovered from anosmia/hyposmia. Regardless of whether the general or olfactory symptoms appeared initially, the general symptoms resolved first while a degree of olfactory dysfunction persisted during the follow-up. Our study showed that hyposmia and anosmia in mild COVID-19 are frequently associated with general and sinonasal symptoms and tend to persist longer than the general and sinonasal symptoms during the course of the disease.
本研究旨在评估嗅觉症状患者和轻度2019冠状病毒病(COVID-19)患者中全身症状和鼻窦症状的患病率,并确定嗅觉/味觉症状相对于全身症状和鼻窦症状出现和缓解的模式。这是一项在一家COVID-19指定转诊医院的门诊耳鼻喉科诊所进行的前瞻性横断面研究。我们纳入了新发嗅觉功能障碍且COVID-19聚合酶链反应(PCR)检测呈阳性的连续患者。我们让患者填写一份关于与嗅觉减退、嗅觉缺失或味觉减退相关的全身症状和鼻窦症状的问卷,并记录随访2周期间嗅觉/味觉症状的时间进程。纳入了76例平均年龄为38.5±10.6岁的患者。大多数参与者(94.7%)有全身或鼻窦症状。嗅觉缺失占60.5%,嗅觉减退占39.5%,63.2%的患者嗅觉症状为突然发作。在随访期间,30.3%的患者嗅觉缺失/嗅觉减退完全恢复,44.7%的患者部分恢复。无论全身症状还是嗅觉症状最初出现,全身症状先缓解,而在随访期间仍存在一定程度的嗅觉功能障碍。我们的研究表明,轻度COVID-19中的嗅觉减退和嗅觉缺失常与全身症状和鼻窦症状相关,且在疾病过程中往往比全身症状和鼻窦症状持续时间更长。